Skip to main content
SpringerLink
Log in

Cytokine Networks and Cancer Stem Cells

  • Chapter
Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology

Abstract

Cell-to-cell communication is an integral function of multicellular organisms. Many of these signals are received by a myriad of cell-surface receptors that utilize a range of intracellular signaling pathways to communicate this to the nucleus, rapidly impacting on the transcription of target genes in order to elicit the desired response, such as proliferation, differentiation, activation, and survival. Dysregulation of these important signaling pathways, and networks, often lead to pathological conditions due to inappropriate cell responses with negative consequences. The aberrant signaling pathways have been associated with many diseases, including cancer. Cytokines and chemokines convey a multitude of messages to the target cell, many of which are beneficial for cancers and cancer stem cells, such as proliferation, survival and migration. By hijacking this communication network, cancers and cancer stem cells can become invasive and more pathogenic. Furthermore, by using these communication systems, cancer stem cells are able to evade current therapies. Therefore, novel therapies may be developed to break the communication systems of the cancer stem cells. This chapter explores the role of the cytokines TGF-β, TNF-α, IL-1 and IL-6 and chemokine CXCL8 as well as NF-κB and their role in cancer stem cell survival and maintenance. Emerging therapies are beginning to target the cancer stem cell population, either specifically or synergistically with existing therapeutic options. These novel therapies may hold the key to breaking the communication network of cancer stem cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abbas T, Dutta A (2009) p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9(6):400–414

    PubMed Central  CAS  PubMed  Google Scholar 

  • Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100(7):3983–3988

    PubMed Central  CAS  PubMed  Google Scholar 

  • Asiedu MK, Ingle JN, Behrens MD, Radisky DC, Knutson KL (2011) TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype. Cancer Res 71(13):4707–4719

    PubMed Central  CAS  PubMed  Google Scholar 

  • Askmyr M, Agerstam H, Hansen N, Gordon S, Arvanitakis A, Rissler M et al (2013) Selective killing of candidate AML stem cells by antibody targeting of IL1RAP. Blood 121(18):3709–3713

    CAS  PubMed  Google Scholar 

  • Balkwill F (2009) Tumour necrosis factor and cancer. Nat Rev Cancer 9(5):361–371

    CAS  PubMed  Google Scholar 

  • Bates RC, Mercurio AM (2003) Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol Biol Cell 14(5):1790–1800

    PubMed Central  CAS  PubMed  Google Scholar 

  • Baud V, Karin M (2009) Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov 8(1):33–40

    PubMed Central  CAS  PubMed  Google Scholar 

  • Ben Musa R, Usha L, Hibbeln J, Mutlu EA (2014) TNF inhibitors to treat ulcerative colitis in a metastatic breast cancer patient: a case report and literature review. World J Gastroenterol 20(19):5912–5917

    PubMed Central  PubMed  Google Scholar 

  • Bhola NE, Balko JM, Dugger TC, Kuba MG, Sanchez V, Sanders M et al (2013) TGF-beta inhibition enhances chemotherapy action against triple-negative breast cancer. J Clin Invest 123(3):1348–1358

    PubMed Central  CAS  PubMed  Google Scholar 

  • Biddle A, Mackenzie IC (2012) Cancer stem cells and EMT in carcinoma. Cancer Metastasis Rev 31:285

    Google Scholar 

  • Biswas SK, Allavena P, Mantovani A (2013) Tumor-associated macrophages: functional diversity, clinical significance, and open questions. Semin Immunopathol 35(5):585–600

    CAS  PubMed  Google Scholar 

  • Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295(19):2275–2285

    CAS  PubMed  Google Scholar 

  • Boulay JL, O’Shea JJ, Paul WE (2003) Molecular phylogeny within type I cytokines and their cognate receptors. Immunity 19(2):159–163

    CAS  PubMed  Google Scholar 

  • Brabletz T (2012) EMT and MET in metastasis: where are the cancer stem cells? Cancer Cell 22(6):699–701

    CAS  PubMed  Google Scholar 

  • Brown ER, Charles KA, Hoare SA, Rye RL, Jodrell DI, Aird RE et al (2008) A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancer. Ann Oncol 19(7):1340–1346

    CAS  PubMed  Google Scholar 

  • Burton ER, Libutti SK (2009) Targeting TNF-alpha for cancer therapy. J Biol 8(9):85

    PubMed Central  PubMed  Google Scholar 

  • Chaffer CL, Brueckmann I, Scheel C, Kaestli AJ, Wiggins PA, Rodrigues LO et al (2011) Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci USA 108(19):7950–7955

    PubMed Central  CAS  PubMed  Google Scholar 

  • Chen L, Fan J, Chen H, Meng Z, Chen Z, Wang P et al (2014) The IL-8/CXCR1 axis is associated with cancer stem cell-like properties and correlates with clinical prognosis in human pancreatic cancer cases. Sci Rep 4:5911

    PubMed Central  CAS  PubMed  Google Scholar 

  • Clevers H (2011) The cancer stem cell: premises, promises and challenges. Nat Med 17(3):313–319

    CAS  PubMed  Google Scholar 

  • Connolly EC, Freimuth J, Akhurst RJ (2012) Complexities of TGF-beta targeted cancer therapy. Int J Biol Sci 8(7):964–978

    PubMed Central  CAS  PubMed  Google Scholar 

  • Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860–867

    PubMed Central  CAS  PubMed  Google Scholar 

  • Cuzick J, Otto F, Baron JA, Brown PH, Burn J, Greenwald P et al (2009) Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol 10(5):501–507

    CAS  PubMed  Google Scholar 

  • D’Anello L, Sansone P, Storci G, Mitrugno V, D’Uva G, Chieco P et al (2010) Epigenetic control of the basal-like gene expression profile via Interleukin-6 in breast cancer cells. Mol Cancer 9:300

    PubMed Central  PubMed  Google Scholar 

  • Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425(6958):577–584

    CAS  PubMed  Google Scholar 

  • Dinarello CA (2010) Why not treat human cancer with interleukin-1 blockade? Cancer Metastasis Rev 29(2):317–329

    PubMed Central  CAS  PubMed  Google Scholar 

  • Dinarello CA (2011) Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117(14):3720–3732

    PubMed Central  CAS  PubMed  Google Scholar 

  • Egea V, von Baumgarten L, Schichor C, Berninger B, Popp T, Neth P et al (2011) TNF-alpha respecifies human mesenchymal stem cells to a neural fate and promotes migration toward experimental glioma. Cell Death Differ 18(5):853–863

    PubMed Central  CAS  PubMed  Google Scholar 

  • Ernst M, Oates A, Dunn AR (1996) Gp130-mediated signal transduction in embryonic stem cells involves activation of Jak and Ras/mitogen-activated protein kinase pathways. J Biol Chem 271(47):30136–30143

    CAS  PubMed  Google Scholar 

  • Fornari F, Milazzo M, Chieco P, Negrini M, Calin GA, Grazi GL et al (2010) MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res 70(12):5184–5193

    CAS  PubMed  Google Scholar 

  • Gales D, Clark C, Manne U, Samuel T (2013) The chemokine CXCL8 in carcinogenesis and drug response. ISRN Oncol 2013:859154

    PubMed Central  PubMed  Google Scholar 

  • Ginestier C, Liu S, Diebel ME, Korkaya H, Luo M, Brown M et al (2010) CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest 120(2):485–497

    PubMed Central  CAS  PubMed  Google Scholar 

  • Greten FR, Arkan MC, Bollrath J, Hsu LC, Goode J, Miething C et al (2007) NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 130(5):918–931

    PubMed Central  CAS  PubMed  Google Scholar 

  • Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140(6):883–899

    PubMed Central  CAS  PubMed  Google Scholar 

  • Gueorguieva I, Cleverly AL, Stauber A, Sada Pillay N, Rodon JA, Miles CP et al (2014) Defining a therapeutic window for the novel TGF-beta inhibitor LY2157299 monohydrate based on a pharmacokinetic/pharmacodynamic model. Br J Clin Pharmacol 77(5):796–807

    PubMed Central  CAS  PubMed  Google Scholar 

  • Guo Y, Xu F, Lu T, Duan Z, Zhang Z (2012) Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev 38(7):904–910

    CAS  PubMed  Google Scholar 

  • Gupta SC, Patchva S, Aggarwal BB (2013) Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J 15(1):195–218

    PubMed Central  CAS  PubMed  Google Scholar 

  • Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57–70

    CAS  PubMed  Google Scholar 

  • Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674

    CAS  PubMed  Google Scholar 

  • Harrison ML, Obermueller E, Maisey NR, Hoare S, Edmonds K, Li NF et al (2007) Tumor necrosis factor alpha as a new target for renal cell carcinoma: two sequential phase II trials of infliximab at standard and high dose. J Clin Oncol 25(29):4542–4549

    CAS  PubMed  Google Scholar 

  • Hartnett L, Egan LJ (2012) Inflammation, DNA methylation and colitis-associated cancer. Carcinogenesis 33(4):723–731

    CAS  PubMed  Google Scholar 

  • Hirsch HA, Iliopoulos D, Tsichlis PN, Struhl K (2009) Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res 69(19):7507–7511

    PubMed Central  CAS  PubMed  Google Scholar 

  • Hussain AR, Ahmed M, Al-Jomah NA, Khan AS, Manogaran P, Sultana M et al (2008) Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt’s lymphoma cell lines. Mol Cancer Ther 7(10):3318–3329

    CAS  PubMed  Google Scholar 

  • Iliopoulos D, Hirsch HA, Wang G, Struhl K (2011) Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion. Proc Natl Acad Sci USA 108(4):1397–1402

    PubMed Central  CAS  PubMed  Google Scholar 

  • Ji Y, Zhang W (2010) Th17 cells: positive or negative role in tumor? Cancer Immunol Immunother 59(7):979–987

    PubMed  Google Scholar 

  • Jing Y, Han Z, Zhang S, Liu Y, Wei L (2011) Epithelial-mesenchymal transition in tumor microenvironment. Cell Biosci 1:29

    PubMed Central  CAS  PubMed  Google Scholar 

  • Jones SA, Scheller J, Rose-John S (2011) Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. J Clin Invest 121(9):3375–3383

    PubMed Central  CAS  PubMed  Google Scholar 

  • Joseph JV, Balasubramaniyan V, Walenkamp A, Kruyt FA (2013) TGF-beta as a therapeutic target in high grade gliomas – promises and challenges. Biochem Pharmacol 85(4):478–485

    CAS  PubMed  Google Scholar 

  • Karin M (2009) NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol 1(5):a000141

    PubMed Central  PubMed  Google Scholar 

  • Karin M, Cao Y, Greten FR, Li ZW (2002) NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2(4):301–310

    CAS  PubMed  Google Scholar 

  • Karin M, Yamamoto Y, Wang QM (2004) The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov 3(1):17–26

    CAS  PubMed  Google Scholar 

  • Katsuno Y, Lamouille S, Derynck R (2013) TGF-beta signaling and epithelial-mesenchymal transition in cancer progression. Curr Opin Oncol 25(1):76–84

    CAS  PubMed  Google Scholar 

  • Knupfer H, Preiss R (2007) Significance of interleukin-6 (IL-6) in breast cancer (review). Breast Cancer Res Treat 102(2):129–135

    PubMed  Google Scholar 

  • Kobilka BK (2007) G protein coupled receptor structure and activation. Biochim Biophys Acta 1768(4):794–807

    PubMed Central  CAS  PubMed  Google Scholar 

  • Koch U, Krause M, Baumann M (2010) Cancer stem cells at the crossroads of current cancer therapy failures–radiation oncology perspective. Semin Cancer Biol 20(2):116–124

    PubMed  Google Scholar 

  • Kong D, Li Y, Wang Z, Sarkar FH (2011) Cancer stem cells and epithelial-to-mesenchymal transition (EMT)-phenotypic cells: are they cousins or twins? Cancers (Basel) 3(1):716–729

    Google Scholar 

  • Korkaya H, Liu S, Wicha MS (2011) Regulation of cancer stem cells by cytokine networks: attacking cancer’s inflammatory roots. Clin Cancer Res 17(19):6125–6129

    PubMed Central  CAS  PubMed  Google Scholar 

  • Korkaya H, Kim GI, Davis A, Malik F, Henry NL, Ithimakin S et al (2012) Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population. Mol Cell 47(4):570–584

    PubMed Central  CAS  PubMed  Google Scholar 

  • Kubiczkova L, Sedlarikova L, Hajek R, Sevcikova S (2012) TGF-beta – an excellent servant but a bad master. J Transl Med 10:183

    PubMed Central  CAS  PubMed  Google Scholar 

  • Kulbe H, Chakravarty P, Leinster DA, Charles KA, Kwong J, Thompson RG et al (2012) A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment. Cancer Res 72(1):66–75

    PubMed Central  CAS  PubMed  Google Scholar 

  • Lee SH, Hong HS, Liu ZX, Kim RH, Kang MK, Park NH et al (2012) TNFalpha enhances cancer stem cell-like phenotype via Notch-Hes1 activation in oral squamous cell carcinoma cells. Biochem Biophys Res Commun 424(1):58–64

    PubMed Central  CAS  PubMed  Google Scholar 

  • Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin AE (2008) Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One 3(8):e3077

    PubMed Central  PubMed  Google Scholar 

  • Li CW, Xia W, Huo L, Lim SO, Wu Y, Hsu JL et al (2012a) Epithelial-mesenchymal transition induced by TNF-alpha requires NF-kappaB-mediated transcriptional upregulation of Twist1. Cancer Res 72(5):1290–1300

    PubMed Central  CAS  PubMed  Google Scholar 

  • Li Y, Wang L, Pappan L, Galliher-Beckley A, Shi J (2012b) IL-1b promotes stemness and invasiveness of colon cancer cells through Zeb1 activation. Mol Cancer 11:87

    PubMed Central  PubMed  Google Scholar 

  • Liang-kuan B, Nan Z, Cheng L, Fu-Ding L, Tian-Xin L, Xu-Jun X et al (2014) Kidney cancer cells secrete IL-8 to activate Akt and promote migration of mesenchymal stem cells. Urol Oncol 32(5):607–612

    Google Scholar 

  • Liu S, Ginestier C, Ou SJ, Clouthier SG, Patel SH, Monville F et al (2011) Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res 71(2):614–624

    PubMed Central  CAS  PubMed  Google Scholar 

  • Liu Z, Bandyopadhyay A, Nichols RW, Wang L, Hinck AP, Wang S et al (2012) Blockade of autocrine TGF-b signaling inhibits stem cell phenotype, survival, and metastasis of murine breast cancer cells. J Stem Cell Res Ther 2(1):1–8

    PubMed Central  PubMed  Google Scholar 

  • Lu H, Ouyang W, Huang C (2006) Inflammation, a key event in cancer development. Mol Cancer Res 4(4):221–233

    PubMed  Google Scholar 

  • Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4):704–715

    PubMed Central  CAS  PubMed  Google Scholar 

  • Massague J (2000) How cells read TGF-beta signals. Nat Rev Mol Cell Biol 1(3):169–178

    CAS  PubMed  Google Scholar 

  • Mayol JF, Loeuillet C, Herodin F, Wion D (2009) Characterisation of normal and cancer stem cells: one experimental paradigm for two kinds of stem cells. Bioessays 31(9):993–1001

    CAS  PubMed  Google Scholar 

  • Medema JP (2013) Cancer stem cells: the challenges ahead. Nat Cell Biol 15(4):338–344

    CAS  PubMed  Google Scholar 

  • Mori Y, Ishida W, Bhattacharyya S, Li Y, Platanias LC, Varga J (2004) Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts. Arthritis Rheum 50(12):4008–4021

    CAS  PubMed  Google Scholar 

  • Morris JC, Tan AR, Olencki TE, Shapiro GI, Dezube BJ, Reiss M et al (2014) Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGFbeta) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma. PLoS One 9(3):e90353

    PubMed Central  PubMed  Google Scholar 

  • Mukaida N, Sasakki S, Popivanova BK (2011) Tumor necrosis factor (TNF) and chemokines in colitis-associated cancer. Cancers (Basel) 3(3):2811–2826

    CAS  Google Scholar 

  • Notara M, Shortt AJ, Galatowicz G, Calder V, Daniels JT (2010) IL6 and the human limbal stem cell niche: a mediator of epithelial-stromal interaction. Stem Cell Res 5(3):188–200

    CAS  PubMed  Google Scholar 

  • Padua D, Massague J (2009) Roles of TGFbeta in metastasis. Cell Res 19(1):89–102

    CAS  PubMed  Google Scholar 

  • Perrot CY, Javelaud D, Mauviel A (2013) Overlapping activities of TGF-beta and Hedgehog signaling in cancer: therapeutic targets for cancer treatment. Pharmacol Ther 137(2):183–199

    CAS  PubMed  Google Scholar 

  • Prasad S, Ravindran J, Aggarwal BB (2010) NF-kappaB and cancer: how intimate is this relationship. Mol Cell Biochem 336(1–2):25–37

    PubMed Central  CAS  PubMed  Google Scholar 

  • Rider P, Carmi Y, Voronov E, Apte RN (2013) Interleukin-1a. Semin Immunol 25(6):430–438

    CAS  PubMed  Google Scholar 

  • Sansone P, Storci G, Tavolari S, Guarnieri T, Giovannini C, Taffurelli M et al (2007) IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest 117(12):3988–4002

    PubMed Central  CAS  PubMed  Google Scholar 

  • Schillace RV, Skinner AM, Pommier RF, O’Neill S, Muller PJ, Naik AM et al (2014) Estrogen receptor, progesterone receptor, interleukin-6 and interleukin-8 are variable in breast cancer and benign stem/progenitor cell populations. BMC Cancer 14(1):733

    PubMed Central  PubMed  Google Scholar 

  • Schlingensiepen KH, Jaschinski F, Lang SA, Moser C, Geissler EK, Schlitt HJ et al (2011) Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer. Cancer Sci 102(6):1193–1200

    CAS  PubMed  Google Scholar 

  • Schroeder RL, Stevens CL, Sridhar J (2014) Small molecule tyrosine kinase inhibitors of ErbB2/HER2/Neu in the treatment of aggressive breast cancer. Molecules 19(9):15196–15212

    PubMed  Google Scholar 

  • Sethi G, Sung B, Aggarwal BB (2008) TNF: a master switch for inflammation to cancer. Front Biosci 13:5094–5107

    CAS  PubMed  Google Scholar 

  • Shackleton M (2010) Normal stem cells and cancer stem cells: similar and different. Semin Cancer Biol 20(2):85–92

    CAS  PubMed  Google Scholar 

  • Shigdar S, Li Y, Bhattacharya S, O’Connor M, Pu C, Lin J et al (2014) Inflammation and cancer stem cells. Cancer Lett 345(2):271–278

    CAS  PubMed  Google Scholar 

  • Simon MC, Keith B (2008) The role of oxygen availability in embryonic development and stem cell function. Nat Rev Mol Cell Biol 9(4):285–296

    PubMed Central  CAS  PubMed  Google Scholar 

  • Singh A, Settleman J (2010) EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29(34):4741–4751

    PubMed Central  CAS  PubMed  Google Scholar 

  • Singh S, Singh AP, Sharma B, Owen LB, Singh RK (2010) CXCL8 and its cognate receptors in melanoma progression and metastasis. Future Oncol 6(1):111–116

    PubMed Central  CAS  PubMed  Google Scholar 

  • Singh JK, Farnie G, Bundred NJ, Simoes BM, Shergill A, Landberg G et al (2013) Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanisms. Clin Cancer Res 19(3):643–656

    CAS  PubMed  Google Scholar 

  • Skov L, Beurskens FJ, Zachariae CO, Reitamo S, Teeling J, Satijn D et al (2008) IL-8 as antibody therapeutic target in inflammatory diseases: reduction of clinical activity in palmoplantar pustulosis. J Immunol 181(1):669–679

    CAS  PubMed  Google Scholar 

  • Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235(4785):177–182

    CAS  PubMed  Google Scholar 

  • Soria G, Ofri-Shahak M, Haas I, Yaal-Hahoshen N, Leider-Trejo L, Leibovich-Rivkin T et al (2011) Inflammatory mediators in breast cancer: coordinated expression of TNFalpha & IL-1beta with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition. BMC Cancer 11:130

    PubMed Central  CAS  PubMed  Google Scholar 

  • Storci G, Sansone P, Mari S, D’Uva G, Tavolari S, Guarnieri T et al (2010) TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype. J Cell Physiol 225(3):682–691

    PubMed Central  CAS  PubMed  Google Scholar 

  • Tanno T, Matsui W (2011) Development and maintenance of cancer stem cells under chronic inflammation. J Nippon Med Sch 78(3):138–145

    PubMed Central  CAS  PubMed  Google Scholar 

  • Tornatore L, Sandomenico A, Raimondo D, Low C, Rocci A, Tralau-Stewart C et al (2014) Cancer-selective targeting of the NF-kappaB survival pathway with GADD45beta/MKK7 inhibitors. Cancer Cell 26(4):495–508

    PubMed Central  CAS  PubMed  Google Scholar 

  • Turzanski J, Grundy M, Russell NH, Pallis M (2004) Interleukin-1b maintains an apoptosis-resistant phenotype in the blast cells of acute myeloid leukaemia via multiple pathways. Leukemia 18(10):1662–1670

    CAS  PubMed  Google Scholar 

  • Wang L, Liu Z, Balivada S, Shrestha T, Bossmann S, Pyle M et al (2012) Interleukin-1b and transforming growth factor-b cooperate to induce neurosphere formation and increase tumorigenicity of adherent LN-229 glioma cells. Stem Cell Res Ther 3(1):5

    PubMed Central  CAS  PubMed  Google Scholar 

  • Wang L, Zhao Y, Liu Y, Akiyama K, Chen C, Qu C et al (2013) IFN-gamma and TNF-alpha synergistically induce mesenchymal stem cell impairment and tumorigenesis via NFkappaB signaling. Stem Cells 31(7):1383–1395

    PubMed Central  CAS  PubMed  Google Scholar 

  • Waugh DJ, Wilson C (2008) The interleukin-8 pathway in cancer. Clin Cancer Res 14(21):6735–6741

    CAS  PubMed  Google Scholar 

  • Weber A, Wasiliew P, Kracht M (2010) Interleukin-1 (IL-1) pathway. Sci Signal 3(105):cm1

    PubMed  Google Scholar 

  • Werman A, Werman-Venkert R, White R, Lee JK, Werman B, Krelin Y et al (2004) The precursor form of IL-1a is an intracrine proinflammatory activator of transcription. Proc Natl Acad Sci USA 101(8):2434–2439

    PubMed Central  CAS  PubMed  Google Scholar 

  • Yamamoto M, Taguchi Y, Ito-Kureha T, Semba K, Yamaguchi N, Inoue J (2013) NF-kappaB non-cell-autonomously regulates cancer stem cell populations in the basal-like breast cancer subtype. Nat Commun 4:2299

    PubMed  Google Scholar 

  • Yin G, Chen R, Alvero AB, Fu HH, Holmberg J, Glackin C et al (2010) TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214. Oncogene 29(24):3545–3553

    PubMed Central  CAS  PubMed  Google Scholar 

  • Zhang J, Wu H, Li P, Zhao Y, Liu M, Tang H (2014) NF-kappaB-modulated miR-130a targets TNF-alpha in cervical cancer cells. J Transl Med 12:155

    PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Medicine, Deakin University, Pigdons Road, Waurn Ponds, Geelong, VIC, 3217, Australia

    Clifford Liongue, Alister C. Ward, Wei Duan & Sarah Shigdar

Authors
  1. Clifford Liongue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alister C. Ward
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wei Duan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sarah Shigdar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sarah Shigdar .

Editor information

Editors and Affiliations

  1. Faculty of Biol. Scs. Dept. of Mol. Gen., Tarbiat Modares University , Tehran, Iran

    Sadegh Babashah

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Liongue, C., Ward, A.C., Duan, W., Shigdar, S. (2015). Cytokine Networks and Cancer Stem Cells. In: Babashah, S. (eds) Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-21030-8_3

Download citation

Publish with us

Policies and ethics

Search

Navigation